Immune Design Reports First Quarter 2015 Financial Results

Go back to Immune Design Reports First Quarter 2015 Financial Results

Cowen Starts Immune Design (IMDZ) at Outperform

May 15, 2015 7:04 AM UTC

Cowen initiated coverage on Immune Design (NASDAQ: IMDZ) with an Outperform rating.

For an analyst ratings summary and ratings history on Immune Design click here. For more ratings news on Immune Design click here.

Shares of Immune Design closed at $21.29 yesterday.

... More

Immune Design (IMDZ) Tops Q1 EPS by 8c

May 14, 2015 7:00 AM UTC

Immune Design (NASDAQ: IMDZ) reported Q1 EPS of ($0.56), $0.08 better than the analyst estimate of ($0.64). Revenue for the quarter came in at $1.9 million versus the consensus estimate of $1.3 million.

For earnings history and earnings-related data on Immune Design (IMDZ) click here.

... More